Ramucirumab Treatment: Uses, Dosage, and Side Effects Explained

Key Points About Ramucirumab Treatment

Ramucirumab is a prescription medication used to treat several types of cancer, including gastric cancer, non-small cell lung cancer, and colorectal cancer. It works by blocking the growth of blood vessels that supply tumors, helping to slow or stop cancer progression. Ramucirumab is typically administered through an intravenous (IV) infusion. Always consult your healthcare provider before starting or adjusting your treatment.

Names of the Medication

US Brand Name: Cyramza

Generic Name: Ramucirumab

The generic name refers to the drug’s chemical composition, while the brand name is assigned by the manufacturer. The generic name is often listed in parentheses.

Pharmacologic Category: VEGFR2 Inhibitor

Ramucirumab belongs to a class of medications known as Vascular Endothelial Growth Factor Receptor (VEGFR) inhibitors. It is a targeted cancer therapy that works by inhibiting angiogenesis, the process by which tumors develop new blood vessels to grow and spread.

Ramucirumab Dosage for Cancer Treatment

Ramucirumab is used to treat various cancers in adults. The dosage depends on the specific type of cancer being treated. Below are the recommended doses for each condition. Always consult your doctor before making any changes to your dose or treatment plan. You can also schedule a telemedicine appointment with one of our providers to discuss your treatment options.

1. Gastric Cancer or Gastroesophageal Junction Cancer: 8 mg/kg every 2 weeks, administered as an intravenous infusion over 60 minutes.
2. Non-Small Cell Lung Cancer: 10 mg/kg every 3 weeks, administered as an intravenous infusion over 60 minutes.
3. Colorectal Cancer: 8 mg/kg every 2 weeks, administered as an intravenous infusion over 60 minutes.
4. Hepatocellular Carcinoma (Liver Cancer): 8 mg/kg every 2 weeks, administered as an intravenous infusion over 60 minutes.
5. Pancreatic Cancer: 8 mg/kg every 2 weeks, administered as an intravenous infusion over 60 minutes.
6. Breast Cancer: 8 mg/kg every 2 weeks, administered as an intravenous infusion over 60 minutes.
7. Ovarian Cancer: 8 mg/kg every 2 weeks, administered as an intravenous infusion over 60 minutes.
8. Head and Neck Cancer: 10 mg/kg every 3 weeks, administered as an intravenous infusion over 60 minutes.
9. Renal Cell Carcinoma (Kidney Cancer): 8 mg/kg every 2 weeks, administered as an intravenous infusion over 60 minutes.

Dosage Forms and Strengths of Ramucirumab

Ramucirumab is available in the following forms for intravenous infusion:

1. Solution for intravenous infusion: 100 mg/10 mL (10 mg/mL)
2. Solution for intravenous infusion: 500 mg/50 mL (10 mg/mL)

Administration Instructions for Ramucirumab

Ramucirumab is administered as an intravenous infusion, meaning it is delivered directly into a vein over a set period of time. The infusion typically lasts about 60 minutes. It is crucial to follow your healthcare provider’s instructions carefully. This medication is usually given in a hospital or clinic setting, where a healthcare professional will monitor you during the infusion. Be sure to attend all scheduled appointments and inform your doctor if you experience any side effects.

Ramucirumab Side Effects and Adverse Reactions

Like all medications, Ramucirumab can cause side effects. Some are more common, while others are rare but potentially serious. If you experience any side effects, contact your healthcare provider immediately. You can also consult one of our telemedicine providers for guidance.

Common Ramucirumab Side Effects

1. Fatigue: Feeling unusually tired or weak.
2. Diarrhea: Loose or watery stools.
3. High Blood Pressure: Elevated blood pressure that may require medication to manage.
4. Decreased Appetite: Reduced desire to eat, which may lead to weight loss.

Serious Ramucirumab Side Effects

1. Bleeding: Ramucirumab can increase the risk of bleeding, including serious bleeding in the stomach or intestines.
2. Blood Clots: This medication may raise the risk of blood clots, which can lead to stroke or heart attack.
3. Gastrointestinal Perforation: A rare but serious condition where a hole forms in the stomach or intestines.
4. Infusion Reactions: Some patients may experience reactions during the infusion, such as fever, chills, or difficulty breathing.

Contraindications for Ramucirumab Treatment

A contraindication is a specific condition or situation in which a medication should not be used because it may cause harm. For Ramucirumab, there are several contraindications that patients should be aware of before starting treatment. These include:

1. Allergy to Ramucirumab or any of its components: If you have a known allergy to Ramucirumab or any of its inactive ingredients, taking this medication could trigger a severe allergic reaction, which could be life-threatening.
2. Uncontrolled high blood pressure (hypertension): Ramucirumab can raise blood pressure. If your blood pressure is not well-controlled, taking this medication could lead to serious complications, such as heart attack or stroke.
3. Recent surgery or poor wound healing: Ramucirumab can interfere with the body’s ability to heal wounds. If you’ve had recent surgery or have a wound that is not healing properly, this medication may increase the risk of complications.
4. Severe bleeding disorders: Ramucirumab can increase the risk of bleeding. If you have a history of bleeding disorders or are currently experiencing bleeding, this medication may worsen your condition.
5. Gastrointestinal perforation: This is a condition where a hole forms in the wall of the stomach or intestines. Ramucirumab can increase the risk of developing this condition, which can be life-threatening.

It’s important to discuss any of these conditions with your healthcare provider before starting Ramucirumab. If you’re unsure whether you have any contraindications, you can schedule a telemedicine visit with one of our providers to review your medical history and determine if Ramucirumab is safe for you.

Drug Interactions with Ramucirumab

Ramucirumab can interact with other medications, potentially affecting its efficacy or increasing the likelihood of side effects. Some medications that may interact with Ramucirumab include:

1. Warfarin (Coumadin): This blood thinner can heighten the risk of bleeding when used alongside Ramucirumab.
2. Aspirin (Bayer, Bufferin): High doses of aspirin may also raise the risk of bleeding when taken with Ramucirumab.
3. Nonsteroidal anti-inflammatory drugs (NSAIDs): Medications such as ibuprofen (Advil, Motrin) and naproxen (Aleve) can increase the risk of bleeding when combined with Ramucirumab.
4. Blood pressure medications: Certain blood pressure medications, including ACE inhibitors (e.g., lisinopril) or angiotensin II receptor blockers (ARBs), may interact with Ramucirumab, potentially leading to side effects like elevated blood pressure.

Always inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. If you have concerns about potential interactions, consider scheduling a telemedicine appointment with one of our providers to review your medication list and discuss any necessary adjustments.

Ramucirumab in Pregnancy: Safety Considerations

Is it safe to take Ramucirumab during pregnancy?

Ramucirumab is not recommended during pregnancy, as it may harm the developing fetus, potentially leading to birth defects or pregnancy loss. If you are pregnant or planning to become pregnant, it is essential to discuss alternative treatment options with your healthcare provider. Should you become pregnant while taking Ramucirumab, contact your healthcare provider immediately to discuss the risks and determine the best course of action. You can also schedule a telemedicine visit with one of our providers to explore safer alternatives during pregnancy.

Ramucirumab While Breastfeeding: What You Need to Know

Is it safe to take Ramucirumab while breastfeeding?

It is not known whether Ramucirumab passes into breast milk. However, due to the potential for serious side effects in a nursing infant, breastfeeding is not recommended while taking Ramucirumab. If you are breastfeeding or plan to breastfeed, it is important to discuss the risks and benefits of continuing or stopping breastfeeding during treatment with your healthcare provider. You can also consult one of our providers through telemedicine to explore your options.

Estimated Cost of Ramucirumab Treatment

The cost of Ramucirumab can vary depending on your location and the pharmacy you use. Without insurance, the estimated cost of a 30-day supply of Ramucirumab using a GoodRX coupon ranges from approximately $10,000 to $15,000. It’s important to check with your pharmacy for the most accurate pricing and to explore potential financial assistance programs if needed.

Possible Alternatives to Ramucirumab Treatment

Depending on the type of cancer being treated, there may be alternative treatments or lifestyle changes that could be beneficial. Always discuss these options with your healthcare provider before making any changes to your treatment plan. Here are some alternatives for cancers treated with Ramucirumab:

1. Gastric cancer: Alternatives may include chemotherapy, radiation therapy, or other targeted therapies such as trastuzumab (Herceptin) if the cancer is HER2-positive. Dietary changes and nutritional support may also help manage symptoms.
2. Gastroesophageal junction cancer: Similar to gastric cancer, treatment options may include chemotherapy, radiation, or targeted therapies. Surgery may also be an option in some cases.
3. Non-small cell lung cancer: Alternatives may include immunotherapy (e.g., pembrolizumab), other targeted therapies, or combination chemotherapy. Smoking cessation and pulmonary rehabilitation may improve outcomes.
4. Colorectal cancer: Alternatives include chemotherapy, immunotherapy, and other targeted therapies like bevacizumab (Avastin). A high-fiber diet and regular exercise may also help manage symptoms.
5. Hepatocellular carcinoma: Treatment options may include liver-directed therapies, such as radioembolization or ablation, as well as systemic therapies like sorafenib (Nexavar).
6. Pancreatic cancer: Alternatives include chemotherapy, radiation, or other targeted therapies. Maintaining a healthy diet and managing pain and digestive symptoms are important lifestyle considerations.
7. Breast cancer: Depending on the type of breast cancer, alternatives may include hormone therapy, chemotherapy, or other targeted therapies such as trastuzumab (Herceptin) or pertuzumab (Perjeta).
8. Ovarian cancer: Alternatives may include chemotherapy, surgery, or targeted therapies like bevacizumab (Avastin). Regular physical activity and a balanced diet may help improve quality of life.
9. Head and neck cancer: Alternatives include surgery, radiation, chemotherapy, or immunotherapy. Smoking cessation and reducing alcohol intake are important lifestyle changes that can improve outcomes.
10. Renal cell carcinoma: Alternatives may include immunotherapy (e.g., nivolumab) or other targeted therapies. Maintaining a healthy weight and staying active may also help manage symptoms.

Always consult with your healthcare provider before making any changes to your treatment plan. If you’re considering alternatives to Ramucirumab, schedule a telemedicine appointment with one of our providers to discuss your options.

Recent Updates on Ramucirumab Research

Recent research on Ramucirumab has focused on its effectiveness when combined with other therapies. For instance, ongoing studies are exploring the use of Ramucirumab in combination with immunotherapy drugs like pembrolizumab (Keytruda) for treating advanced cancers, including non-small cell lung cancer and gastric cancer. Early results suggest that combining these therapies may improve outcomes for some patients. Additionally, researchers are investigating the potential benefits of Ramucirumab in other cancer types, such as ovarian and breast cancer.

As research continues, new treatment protocols may emerge that could enhance the effectiveness of Ramucirumab or expand its use to other cancer types. If you’re interested in learning more about the latest research or clinical trials involving Ramucirumab, speak with your healthcare provider or schedule a telemedicine consultation with one of our providers.

James Kingsley

Learn More